Kismet
AdobeStock_162640208.jpeg

Shared Journey Fertility Program

 

We have extensive knowledge and experience in working with women who have experienced fertility challenges due to endometriosis, PCOS, diminished ovarian reserve, blocked fallopian tubes, recurring miscarriage, failed medical attempts such as IVF and secondary fertility issues.


The Shared Journey Fertility Program

DSC_0144__Version_2-1024x731.jpg

Our fertility program is 6 weeks in length and can be used as a stand alone regime or in preparation for a more medically assisted cycle such as IUI or IVF. It is highly recommend that you prepare your body properly prior to starting any medically assisted fertility cycle to help insure a successful first cycle. The Shared Journey can be completed in time for your stim start. 

 You will be guided to monitor your own ovulatory cycle along with our help for up to one year after finishing your therapy with us. 

The program is custom tailored to each individual woman's situation and will be discussed in further detail at a consultation. 

Mercier Therapy is a deep pelvic organ visceral manipulation modality. When increasing blood flow, you're optimizing the true function of the area and helping to return blood flow which is therapeutic. When choosing to start the SJFP you'll receive 6 full hours of MT broken down into 1 hour intervals per week for 6 weeks. 


Articles have been written about soft tissue abdominal and pelvic work alleviating fertility challenges, but no clinical research has been performed. The purpose of this study is to confirm that the use of Merciér Therapy—site-specific, manual soft tissue therapy—is valid as a standalone treatment and with assisted reproductive technologies to help women become pregnant.

Forty-eight women ages 28–42 were interviewed and underwent at least two sessions of Merciér Therapy. Merciér Therapy’s research setting is a holistic, clinical, multidisciplinary environment in Illinois and Arkansas. The women selected for the study all complained of primary and secondary fertility challenges regardless of age, current or past pathological condition, prior surgical intervention, prior treatment, and history of no treatment.

Eighteen women achieved pregnancy within the first six months of their first Merciér Therapy sessions. Twenty-two women achieved pregnancy within one year of their first Merciér Therapy session. Eight women did not become pregnant. Of the forty women who became pregnant, thirty-two used Merciér Therapy as a standalone treatment; six used in-vitro fertilization; two used a combination of Clomid and intrauterine insemination.

Merciér Therapy has proven beneficial in helping couples to achieve pregnancy in a diverse group of women with various prior assisted reproductive technology backgrounds, ages, races, current pathologies, and medical histories.